Reactive Additives in Membrane Manufacturing
By contacting the cross-linking reaction between the spinning solution and the pore solution in the spinneret, a modified microporous membrane was generated, which solved the problem of poor water wettability and insufficient stability of the hydrophobic membrane in the filtration of aqueous media, and achieved improvement Hydrophobicity and the effect of reducing extractables are suitable for efficient filtration and viral filtration.
Patent Information
- Application Number
- CN202080046289.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-06-27
- Filing Date
- 2020-06-23
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2040-06-23
AI Technical Summary
The existing hydrophobic sulfone polymer membranes have poor water wetting and protein adsorption problems in aqueous media filtration, resulting in poor permeability and membrane scaling. They are not stable under high pressure, making them difficult to be suitable for ultrafiltration applications.
A spinning solution containing the first polymer and epoxy functional compound is contacted with a pore solution of the diamine compound in the spinneret, and a modified microporous membrane is generated by cross-linking reaction, which improves the hydrophobicity of the membrane and reduces the extractable maintain good flux and retain properties.
The obtained modified membranes exhibit enhanced hydrophobicity, reduce "scaling" behavior, improve filtration and retention properties, and are suitable for aqueous media filtration, especially with excellent performance in viral filtration.
Smart Images

Figure BDA0003429944860000051 
Figure BDA0003429944860000061 
Figure BDA0003429944860000111
Abstract
Description
Technical Field
[0001] The present disclosure relates to a method for manufacturing a modified microporous membrane. In addition, the present disclosure relates to a membrane obtained by such a method. The present disclosure also relates to the use of such a membrane for filtering and purifying a liquid medium. Background Art
[0002] Polymer membranes are used in a very wide range of different industrial, pharmaceutical or medical applications for fine filtration. In these applications, membrane separation methods are becoming increasingly important because these methods provide the advantage of not being subjected to thermal burden or even damage to the substances to be separated. Ultrafiltration membranes can be used to remove or separate macromolecules. Many further applications of membrane separation methods are known in beverage industry, biotechnology, water treatment or sewage treatment technology. Such membranes are usually classified according to their retention capacity, i.e., according to the capacity of retaining particles or molecules of a certain size, or about the size of the effective pores, i.e., the size of the pores that determine the separation behavior. Therefore, ultrafiltration membranes cover a size range of the pores that determine the separation behavior between approximately 0.01 μm and approximately 0.1 μm, so that particles or molecules with a size greater than 20,000 Dalton or greater than approximately 200,000 Dalton can be retained.
[0003] In many cases, membranes made of sulfone polymers such as polysulfone or polyethersulfone are used for applications in the field of ultrafiltration, not only due to their high chemical stability towards acids or bases, their temperature stability or the sterilizability of membranes made of these materials.
[0004] US-A-5,928,774 discloses asymmetric ultrafiltration membranes in the form of flat membranes made of sulfone polymers. The membranes in US-A-5,928,774 exhibit a pronounced asymmetry; on one of their surfaces, they have a separation layer in the form of a surface layer, and adjacent to this separation layer is a support layer, the pore structure of which does not contain cavities (also called finger-like pores or macrovoids), and the pores of which gradually become larger from the surface layer towards the second surface. Due to their pronounced asymmetry, the membranes in US-A-5,928,774 are optimized for high transmembrane flow rates and high dirt loading capacity in applications. Similar flat membranes made of polyethersulfone with pronounced asymmetry are also described in US-A-5,886,059.
[0005] Since the semipermeable membranes described in the publication cited above are made of hydrophobic sulfone polymers, their water wettability is poor, making their use in aqueous medium filtration very limited. In addition, it is known that hydrophobic membranes have strong, non-specific adsorption capabilities such as proteins, so that the membrane surface is often quickly coated by the higher molecular weight components mainly from the liquid to be filtered during use, thereby causing the permeability to deteriorate. This phenomenon is generally referred to as "membrane scaling". In order to improve water wettability and therefore improve the permeability to aqueous media, and in order to avoid protein adhesion to the membrane surface, multiple attempts have been made to make the membrane based on sulfone polymer hydrophilic while reducing the tendency of adsorbing proteins. According to one of these methods, a hydrophilic polymer such as polyvinyl pyrrolidone is mixed with a sulfone polymer during the manufacturing process.
[0006] EP-A-568045 relates to a hollow fiber membrane based on hydrophilic polysulfone with an asymmetric structure, which contains polyglycol and a polymer based on vinylpyrrolidone to ensure hydrophilic properties. The hollow fiber membrane in EP-A-568045 has a 0.1 μm to 3 μm thick separation layer on its side facing the inner cavity, which has a 0.001 to 0.05 wide slot-shaped hole on the inner surface. This separation layer is adjacent to a support layer with a reticular or sponge-like structure and holes with an average size of 1 μm to 5 μm. On the outer surface is a layer with a reticular or sponge-like structure that is denser than the support layer.
[0007] The cut-off values of the membranes in EP-A-568045 can be specified as being in the ultrafiltration range, although the membranes are optimized for blood processing. In the examples given in EP-A-568045, the water permeability of the hollow fiber membranes is approximately at most about 0.7 ml / cm 2 However, these membranes have a wall thickness of 40 μm and are therefore relatively thin-walled and are therefore not suitable for ultrafiltration applications due to their insufficient pressure and breakage stability.
[0008] There remains a need in the art for methods for making polymer membranes, particularly PES membranes, which result in modified membranes having enhanced hydrophobicity and ideally reduced amounts of extractables without any degradation in filtration or flux / retention properties. Summary of the invention
[0009] The present disclosure provides a method for manufacturing a modified microporous membrane, comprising:
[0010] (i) providing a first solution comprising at least one first polymer and at least one epoxy-functional compound;
[0011] (ii) providing a second solution comprising at least one diamine compound;
[0012] (iii) contacting the first solution with the second solution to obtain a modified microporous membrane comprising at least one first polymer and a crosslinked reaction product of at least one epoxy-functional compound and at least one diamine compound;
[0013] wherein the modified microporous membrane is a hollow fiber membrane; and
[0014] The first solution is a spinning solution, and the second solution is a pore solution, and the first solution and the second solution are brought into contact in a spinneret.
[0015] The present disclosure also provides a membrane obtained according to the method as described herein.
[0016] Furthermore, the present disclosure relates to certain uses of the membranes as described herein for use in filtration of aqueous media, in particular in virus filtration. DETAILED DESCRIPTION
[0017] Before explaining any embodiment of the present disclosure in detail, it should be understood that the application of the present disclosure is not limited to the details of the construction and component arrangement given in the following description. The present invention can have other embodiments and can be practiced or implemented in various ways. As used herein, the terms "one", "a kind of" and "said" are used interchangeably and mean one or more; and "and / or" is used to indicate that one or two described situations may occur, such as A and / or B includes (A and B) and (A or B). Moreover, in this article, the range expressed by the endpoint includes all numbers contained in the range (for example, 1 to 10 includes 1.4, 1.9, 2.33, 5.75, 9.98, etc.). Moreover, in this article, the expression "at least one" includes all numbers greater than one (for example, at least 2, at least 4, at least 6, at least 8, at least 10, at least 25, at least 50, at least 100, etc.). Moreover, it should be understood that the wording and terms used herein are for illustrative purposes and should not be regarded as restrictive. In contrast to the use of "consisting of," which is intended to be limiting, the use of "including," "containing," "comprising," or "having" and variations thereof are intended to be non-limiting and encompass the items listed thereafter as well as additional items.
[0018] Unless otherwise indicated, the amount of a component of a composition may be indicated in % by weight (or "% wt" or "wt.-%). Unless otherwise indicated, the amounts of all components are given as 100 wt.%. If the amount of a component is indicated in mole %, the amounts of all components are given as 100 mole % unless otherwise indicated.
[0019] The parameters as described herein can be determined as detailed in the experimental section.
[0020] Unless explicitly indicated otherwise, all preferred ranges and embodiments are freely combinable.
[0021] The present disclosure provides a method for manufacturing a modified microporous membrane, comprising:
[0022] (i) providing a first solution comprising at least one first polymer and at least one epoxy-functional compound;
[0023] (ii) providing a second solution comprising at least one diamine compound;
[0024] (iii) contacting the first solution with the second solution to obtain a modified microporous membrane comprising at least one first polymer and a crosslinked reaction product of at least one epoxy-functional compound and at least one diamine compound;
[0025] wherein the modified microporous membrane is a hollow fiber membrane; and
[0026] The first solution is a spinning solution, the second solution is a pore solution, and the first solution and the second solution are brought into contact in a spinneret.
[0027] The method provides a convenient, efficient and reliable method for making modified membranes, especially hollow fiber membranes, which results in microporous membranes modified by cross-linked epoxy compounds. This controlled incorporation of diamine cross-linked epoxy compounds has the effect of providing a membrane having enhanced hydrophobicity, reduced extractables compared to unmodified membranes, while still exhibiting good flux, filtration and retention properties. This enhanced and improved hydrophobicity of the membranes obtained by the method described herein can have the following advantages: improved wettability of the membrane, reduced "fouling" behavior, and improved filtration and / or retention properties.
[0028] In general, epoxy-functional compounds are hydrocarbon-based compounds having at least one epoxy moiety suitable for crosslinking. More specifically, epoxy-functional compounds are oligomers, polymers or copolymers, and the oligomers, polymers or copolymers include building blocks comprising at least one epoxy moiety. Preferably, at least one epoxy-functional compound is a copolymer, and the copolymer includes building blocks comprising at least one epoxy moiety and at least one aliphatic or aromatic functional group. In this regard, it is preferred that at least one epoxy-functional compound exhibits an aliphatic backbone. That is, the core carbon-carbon connection between the various building blocks is preferably of aliphatic nature. In addition, it is preferred that the building blocks having at least one epoxy moiety are selected from aliphatic or aromatic ethers or esters. Preferably, the copolymer further comprises a building block having a moiety selected from the group consisting of: aliphatic, cyclic or aromatic esters; aliphatic, cyclic or aromatic amides; aliphatic, cyclic or aromatic ethers; aliphatic, cyclic or aromatic sulfones; aliphatic, cyclic or aromatic sulfides; aliphatic, cyclic or aromatic sulfonamides; and / or metal chelators. This has the advantage that the selected functionality can be selectively built into at least one epoxy-functional compound. This means that the membrane properties can be modified intentionally and purposefully. For example, hydrophobicity or hydrophilicity can be enhanced, charges can be introduced (e.g., via cations or anions), protein docking sites, chelators or even medical active agents can be introduced and thus built into the membrane. This may be advantageous for many applications in industry or, in particular, in the pharmaceutical or medical fields. It is also preferred that the copolymer of epoxy-functional compounds as described herein also has a building block selected from building blocks comprising cyclic amides, cyclic or aliphatic esters and / or aliphatic or cyclic silanes. Preferably, the further building blocks are selected from pyrrolidones, caprolactams, acetates and / or formates.
[0029] Preferably, at least one epoxy-functional compound has the formula (I)
[0030]
[0031] wherein x, y and z are uniformly distributed. Preferably, the sum of x+y+z is at most at least 50, preferably at least 60, more preferably at least 70. In this regard, it is also preferred that the sum of x+y+z is at most 140 and less, preferably 130 and less, and more preferably 120 and less. Preferably, the sum of x+y+z is at most a number in the range of 50 to 140, preferably 60 to 130, and more preferably 70 to 120. It was found that epoxy-functional compounds of formula (I) with x, y and z within these ranges are easily and reliably crosslinked in the methods described herein and produce films with enhanced hydrophobicity and reduced extractables compared to films that do not contain these crosslinking compounds. The first solution used in the method according to the present disclosure comprises at least one epoxy-functional compound in an amount ranging from 0.1 wt % to 15 wt %, preferably in a range of 0.5 wt % to 10 wt %, and more preferably in a range of 1 wt % to 7 wt %, based on the total weight of the first solution.
[0032] Generally speaking, any diamine known to the skilled person for crosslinking epoxy functional compounds can be used as at least one diamine compound within the scope of the present disclosure. In order to obtain reliable and optimal crosslinking results in the film obtained in the method according to the present disclosure, it is preferred that at least one diamine compound is selected from polyamines, polyetheramines, polyamidoamides and any combination and mixture thereof. For example, a diamine compound suitable for the method according to the present disclosure is a polyetheramine commercially available from Huntsman Corp. under the trade name "Jeffamine", such as "Jeffamine ED-2003". The second solution used in the method according to the present disclosure comprises at least one diamine, and the amount of the at least one diamine is in the range of 1% to 20% by weight, preferably 2% to 15% by weight, and more preferably in the range of 3% to 10% by weight, based on the total weight of the second solution.
[0033] In the method according to the present disclosure, the membrane is spun by spinning a uniform first solution (i.e., a spinning solution) and a second uniform solution (i.e., a pore solution) through a spinneret. The first solution comprises at least one first polymer and at least one first epoxy-functional compound in a solvent system. For the at least one first polymer used in the method as described herein, substantially any polymer known in the art for making microporous membranes can be used. Preferably, at least one first polymer is selected from polyvinylidene fluoride, polyethylene and / or polysulfone. These polymers produce stable microporous membranes that exhibit good filtration properties, good flux, and good mechanical properties required for industrial manufacture of the membrane and many applications of the membrane itself in industrial and / or pharmaceutical or medical use. In the method as described herein, it is preferred that at least one first polymer is selected from polysulfones, preferably polyethersulfones, polyphenylsulfones or polyarylethersulfones. In particular, hydrophobic aromatic sulfone polymers are preferred.
[0034] Advantageous hydrophobic aromatic sulfone polymers used in the method according to the invention are polysulfone, polyethersulfone, polyphenylsulfone or polyaryl ethersulfone. Preferably, the hydrophobic aromatic sulfone polymer is a polysulfone or polyethersulfone having repeating molecular units shown in the following formulas (II) and (III):
[0035]
[0036] At least one polymer such as at least one polysulfone polymer may also include additives such as antioxidants, nucleating agents, ultraviolet absorbers, etc., to selectively modify membrane properties. According to the present disclosure, based on the total weight of the first solution, the concentration of at least one first polymer in the first solution is preferably in the range of 10 wt % to 40 wt %, preferably 12 wt % to 35 wt %, and more preferably 15 wt % to 30 wt %. Concentrations below 10 wt % may result in disadvantages, particularly with respect to the mechanical stability of the resulting hollow fiber membrane. On the other hand, the membrane obtained from the spinning solution having more than 40 wt % of the first polymer may exhibit an overly dense structure and insufficient permeability.
[0037] In this regard, it is preferred that the first solution also contains at least one second polymer. The at least one second polymer is preferably a hydrophilic polymer or copolymer that is advantageously used in combination with the hydrophobic aromatic sulfone used as the at least one first polymer in the first solution used in the method as described herein. Long-chain polymers are advantageously used as at least one second polymer, i.e. at least one hydrophilic polymer, which on the one hand exhibits compatibility with the hydrophobic aromatic sulfone polymer and has repeating polymer units that are themselves hydrophilic. Preferably, an average molecular weight M WThe hydrophilic polymer is preferably a hydrophilic polymer having a hydrophilicity greater than 10,000 daltons, preferably greater than 20,000 daltons, more preferably greater than 30,000 daltons. The hydrophilic polymer is preferably polyvinyl pyrrolidone, polyethylene glycol, polyvinyl alcohol, polyglycol monoester, polysorbate such as polyoxyethylene sorbitan monooleate, carboxymethyl cellulose or a modified substance or copolymer of these polymers and any combination and mixture thereof. Polyvinyl pyrrolidone and polyethylene glycol are particularly preferred. In a particularly preferred embodiment of the present disclosure, at least one first polymer is selected from polysulfones as described herein, and at least one second polymer is selected from polyvinyl pyrrolidone.
[0038] In the context of the present disclosure, the at least one hydrophilic polymer may also comprise a mixture of different hydrophilic polymers. For example, the hydrophilic polymer may be a mixture of chemically different hydrophilic polymers or hydrophilic polymers with different molecular weights, such as a mixture of polymers with molecular weights that differ by 5 times or more. Preferably, the at least one hydrophilic polymer comprises a mixture of polyvinyl pyrrolidone or polyethylene glycol and a hydrophilically modified aromatic sulfone polymer. It is also preferred that the hydrophilically modified aromatic sulfone polymer is a sulfonated aromatic sulfone polymer, particularly a sulfonated modification of a hydrophobic aromatic sulfone polymer used in a membrane and method as described in the present disclosure. A mixture of polyether sulfone, sulfonated polyether sulfone and polyvinyl pyrrolidone may be particularly advantageously employed. As a result of the presence of a hydrophilically modified aromatic sulfone polymer, a hollow fiber membrane having a particularly stable hydrophilic property in an application may be obtained. Preferably, the first solution comprises at least one second polymer in an amount ranging from 2 wt % to 25 wt %, preferably from 5 wt % to 20 wt %, and more preferably from 7.5 wt % to 15 wt %, based on the total weight of the first solution.
[0039] The first solution comprises at least one solvent or solvent system that matches at least one first polymer and at least one second polymer (if present). For example, the solvent system to be adopted must match the hydrophobic aromatic sulfone polymer and at least one hydrophilic polymer adopted so that a uniform spinning solution can be manufactured. The solvent system preferably comprises a polar aprotic solvent such as dimethylformamide, dimethylacetamide, dimethyl sulfoxide, N-methylpyrrolidone or a mixture thereof, or a protic solvent such as ε-caprolactam. In addition, the solvent system may comprise up to 80% by weight of a potential solvent, whereby in the context of the present invention, the potential solvent is understood to be a solvent that is difficult to dissolve the sulfone polymer or only dissolves the sulfone polymer at high temperatures. For example, in the case of using ε-caprolactam as a solvent, γ-butyrolactone, propylene carbonate or polyalkylene glycol may be used. In addition, the solvent system may comprise a non-solvent for a film-forming polymer, such as water, glycerol, a low molecular weight polyethylene glycol or a low molecular weight alcohol such as ethanol or isopropanol having an average molecular weight less than 1000 daltons. In a preferred example of the solvent system according to the present disclosure, the solvent system in the first solution comprises N-methylpyrrolidone and water. Preferably, the first solution comprises N-methylpyrrolidone in an amount ranging from 40 wt % to 80 wt %, preferably from 50 wt % to 75 wt %, and more preferably from 55 wt % to 70 wt %.
[0040] After preferably degassing and filtering to remove insoluble particles, the uniform first solution is extruded through the annular gap of a conventional hollow fiber die (i.e., a spinneret) to manufacture a hollow fiber. The second solution (or pore solution) is extruded through a central nozzle opening coaxially arranged with the annular gap in the hollow fiber die / spinneret, i.e., a coagulation medium that contains at least one diamine compound and can be a hydrophobic aromatic sulfone polymer and simultaneously stabilizes the internal filler of the hollow fiber lumen. In the present disclosure, the terms "hollow fiber die" and "spinneret" are used interchangeably. The second solution preferably includes at least one solvent selected from dimethylformamide, dimethylacetamide, dimethyl sulfoxide and N-methylpyrrolidone and any combination and mixture thereof. Preferably, the second solution also includes a non-solvent of a film-forming polymer, such as water, glycerol, a low molecular weight polyethylene glycol or a low molecular weight alcohol such as ethanol or isopropanol having an average molecular weight less than 1000 daltons, and / or a protic solvent such as caprolactam. For example, the second solution may include water and glycerol, but may also include additional ingredients and / or solvents.
[0041] The width of the annular gap and the inner diameter of the central nozzle opening can be selected according to the desired properties of the hollow fiber membrane known in the art. That is, the spinneret can present a spinneret outer diameter suitable for the spinning solution in the range of 1100 μm to 3000 μm, a spinneret needle outer diameter in the range of 600 μm to 2000 μm, and a spinneret needle inner diameter in the range of 400 μm to 1500 μm.
[0042] After leaving the hollow fiber die (i.e. the spinneret) and before entering the coagulation medium, it is preferred that the hollow fibers pass through a climate-controlled area with defined climatic conditions. The climate-controlled area can thus take the form of, for example, an encapsulation chamber. For technical reasons, an air gap may need to exist between the hollow fiber die and the climate-controlled area. However, this gap should advantageously be as small as possible; the climate-controlled area preferably follows the hollow fiber die.
[0043] In this regard, it is preferred that the hollow fibers have a residence time of 0.5 to 10 seconds in the climate-controlled area, whereby the climate-controlled area contains air with a relative humidity of 40% to 95% and a temperature of 50° C. to 70° C. The air contained in the climate-controlled area preferably has a relative humidity of 55% to 85%. It is also preferred that the residence time of the hollow fibers in the climate-controlled area is 1 to 7 seconds. In order to establish stable conditions in the climate-controlled area, the air preferably flows through the climate-controlled area at a speed of less than 0.5 m / s and particularly preferably at a speed in the range of 0.15 m / s to 0.35 m / s.
[0044] As the hollow fibers are directed through a climate-controlled zone set to the preferred climate conditions in the method according to the present disclosure, pre-condensation of the hollow fibers is induced by absorption of air moisture acting as a non-solvent on the exterior of the hollow fibers.
[0045] After passing through the climate-controlled area, the pre-coagulated hollow fibers can be guided through an aqueous coagulation medium preferably adjusted to 50° C. to 80° C. in order to complete the formation of the membrane structure and fix the membrane structure. The coagulation medium is preferably adjusted to a temperature in the range of 60° C. to 75° C. Preferably, the coagulation medium is water or a water bath.
[0046] In the coagulation medium, the membrane structure is first precipitated to such an extent that it has sufficient stability and can be turned in the coagulation medium, for example on deflection rollers or similar means. In a further step of the method, coagulation is completed and the membrane structure is stabilized. The extraction of the solvent system and the solubles takes place simultaneously. Generally speaking, the majority of the hydrophilic polymer, for example polyvinyl pyrrolidone, is extracted from the membrane structure, so that the coagulation bath and the washing or extraction bath act simultaneously. Water is preferably used as the coagulation or washing medium in these coagulation or washing baths.
[0047] After extraction, the hollow fiber membrane thus obtained can be dried, and the dried membrane is then rolled up. In the extraction and drying process of the membrane, in order to selectively set certain membrane properties, such as surface porosity and separation characteristics, slight drawing may be advantageous. Then the hollow fiber membrane according to the present disclosure can be textured (if necessary) to improve the exchange properties of the hollow fiber membrane in the membrane bundle. Finally, conventional methods can be used to process the hollow fiber membrane, such as being wound on a coil or directly forming a bundle with a suitable fiber number and length. Before manufacturing the bundle, a supplementary line such as a multifilament yarn form can be added to the hollow fiber membrane to ensure that the spacing of the hollow fiber membrane relative to each other and the better flow of the single hollow fiber membrane around the bundle.
[0048] By means of the method as described herein, a membrane according to the present disclosure is obtained having the advantageous structure and properties as described herein.
[0049] Due to the unique combination of properties of the hollow fiber membrane as described herein obtained from the method as described herein, the present disclosure also provides the use of the membrane as described herein for microfiltration, nanofiltration or ultrafiltration. "Microfiltration", "nanofiltration" and "ultrafiltration" have the usual meanings in the art. Preferably, the use as described herein is water filtration or filtration of aqueous media. In this regard, the use according to the present disclosure is included in the filtration in the pharmaceutical industry, biopharmaceutical industry, medical applications, the processing of residential water and food and beverage filtration.
[0050] The present disclosure may be further illustrated by the following exemplary and preferred items:
[0051] Project 1: A method for manufacturing a modified microporous membrane, comprising:
[0052] (i) providing a first solution comprising at least one first polymer and at least one epoxy-functional compound;
[0053] (ii) providing a second solution comprising at least one diamine compound;
[0054] (iii) contacting the first solution with the second solution to obtain a modified microporous membrane comprising at least one first polymer and a crosslinked reaction product of at least one epoxy-functional compound and at least one diamine compound;
[0055] The modified microporous membrane is a hollow fiber membrane;
[0056] The first solution is a spinning solution, the second solution is a pore solution, and the first solution and the second solution are brought into contact in a spinneret.
[0057] Item 2: The method according to any of the preceding items, wherein at least one epoxy functional compound is a copolymer comprising building blocks comprising at least one epoxy moiety and at least one aliphatic or aromatic alkoxy functional group.
[0058] Item 3: The method according to Item 2, wherein the building block comprising at least one epoxy moiety is selected from aliphatic or aromatic glycidyl ethers.
[0059] Item 4: A method according to Item 2 or Item 3, wherein the copolymer also includes a building block having a portion selected from the following: aliphatic, cyclic or aromatic esters; aliphatic, cyclic or aromatic amides; aliphatic, cyclic or aromatic ethers; aliphatic, cyclic or aromatic sulfones; aliphatic, cyclic or aromatic sulfides; aliphatic, cyclic or aromatic sulfonamides; and / or metal chelators.
[0060] Item 5: According to the method of Item 4, the additional building blocks are selected from building blocks comprising cyclic amides, cyclic or aliphatic esters and / or aliphatic or cyclic silanes.
[0061] Item 6: The method according to Item 4 or Item 5, wherein the additional building blocks are selected from building blocks comprising pyrrolidone, caprolactam, acetate and / or formates.
[0062] Item 7: The method according to any one of the preceding items, wherein at least one epoxy functional compound has formula (I)
[0063]
[0064] where x, y and z are uniformly distributed.
[0065] Item 8: The method according to Item 7, wherein x+y+z=100.
[0066] Item 9: The method according to any one of the preceding items, wherein the at least one diamine compound is selected from polyamines, polyetheramines, polyamidoamines, and any combinations and mixtures thereof.
[0067] Item 10: The method according to any one of the preceding items, wherein the at least one first polymer is selected from polyvinylidene fluoride, polyethylene and / or polysulfone.
[0068] Item 11: The method according to Item 10, wherein at least one first polymer is selected from polysulfones, preferably selected from polyethersulfones, polyphenylsulfones or polyarylethersulfones.
[0069] Item 12: The method according to any of the preceding items, wherein the first solution comprises at least one second polymer.
[0070] Item 13: The method according to Item 12, wherein at least one second polymer is a hydrophilic polymer or copolymer.
[0071] Item 14: The method according to Item 11 or Item 12, wherein at least one first polymer is selected from polysulfone, and at least one second polymer is selected from polyvinylpyrrolidone.
[0072] Item 15: The method according to any one of the preceding items, wherein the first solution comprises at least one solvent.
[0073] Item 16: The method according to Item 15, wherein at least one solvent is selected from dimethylformamide, dimethylacetamide, dimethyl sulfoxide and N-methylpyrrolidone and any combination or mixture thereof.
[0074] Item 17: The method according to Item 15 or Item 16, wherein the first solvent further comprises at least one protic solvent preferably selected from ε-caprolactam, water, γ-butyrolactone, propylene carbonate and polyalkylene glycol, and any combination or mixture thereof.
[0075] Item 18: The method according to Item 17, wherein the first solution comprises water and / or N-methylpyrrolidone.
[0076] Item 19: The method according to any one of the preceding items, wherein the second solution comprises at least one solvent selected from dimethylformamide, dimethylacetamide, dimethyl sulfoxide and N-methylpyrrolidone, and any combination or mixture thereof.
[0077] Item 20: The method according to Item 19, wherein the second solution further comprises at least one protic solvent preferably selected from the group consisting of ε-caprolactam, water, γ-butyrolactone, propylene carbonate and polyalkylene glycol, and any combination or mixture thereof.
[0078] Item 21: The method according to Item 19 or Item 20, wherein the second liquid comprises water and / or N-methylpyrrolidone.
[0079] Item 22: A modified membrane obtained in the method according to any one of items 1 to 21.
[0080] Item 23: Use of the membrane according to Item 22 for microfiltration, nanofiltration or ultrafiltration.
[0081] Item 24: The use according to Item 23, wherein the use comprises water filtration or filtration of aqueous media.
[0082] Item 25: The use according to Item 23 or Item 25, wherein the use includes filtration in the pharmaceutical industry, the biopharmaceutical industry, medical applications, treatment of residential water, and food and beverage filtration.
[0083] Item 26: The use according to any one of Items 23 to 25, wherein the use comprises virus filtration.
[0084] Example
[0085] The present disclosure is further described, however, it is not intended to be limited thereto. The following examples are provided to illustrate certain embodiments but are not intended to be limiting in any way. Prior to this, some test methods for characterizing materials and their properties will be described. Unless otherwise indicated, all parts and percentages are by weight.
[0086] Test Method
[0087] Determination of nitrogen content of membranes
[0088] The nitrogen content of the film is determined according to the Kjeldahl procedure in the corresponding equipment. About 1g of the dried film sample is carefully weighed into a glass vial, accurate to 0.1mg. Spezial-Kjeltabs Cu / 3,5- tablets and 16mL concentrated sulfonic acid are carefully added to the sample. Triple determination is performed. For blank value determination, three samples containing only Spezial-Kjeltabs Cu / 3,5- tablets and 16mL concentrated sulfonic acid are prepared. The vial is placed in the corresponding holder in the Kjehldahl device, and the procedure is performed in vacuum at 400°C. When a clear blue solution is formed in the glass vial, the procedure is considered to be complete. Then, the NH3 content in the vial is determined by titration with HCl, and the corresponding nitrogen content is calculated.
[0089] Determination of residual extractables by UV spectroscopy
[0090] About 1.5 g of the film sample was weighed into a conical flask, accurate to 0.1 mg. 150 mL of ultrapure water, pre-boiled and cooled to room temperature, was added. The sealed flask was then shaken at 70° C. for 1 hour and then cooled to room temperature. The eluate was then subjected to UV spectral analysis at a wavelength in the range of 350 nm to 250 nm (at intervals of 10 nm). The highest extinction value in the wavelength region was taken as the measured value.
[0091] Example 1: Modified hollow fiber membrane
[0092] A spinning solution having a composition as shown in Table 1 was set. The VP / VA / GMA copolymer used in Table 1 is a copolymer obtained from Ashland having the following general formula 1, wherein x, y and z are randomly distributed, and wherein x+y+z=100.
[0093]
[0094] Formula 1: VP / VA / GMA polymer.
[0095] Using the pore liquid containing diamine (Jeffamine ED-2003) according to the composition shown in Table 1, the spinning of the hollow fiber membrane is performed at a spinning speed of 40m / min through a spinneret with a temperature of 50°C. Spinning is performed at a speed of 40m / min, wherein the coagulation bath temperature is 65°C. The pore liquid has a temperature of 35°C. The residence time of the reaction between the two components at the interface between the pore liquid and the polymer spinning solution is expected to be 38 seconds. The spinneret temperature is 50°C. The counterpart of the epoxy functional compound according to Formula 1 (i.e., diamine) is added to the pore liquid (5% in the NMP / water mixture). When the spinning solution solution contacts the pore liquid, the crosslinking between the epoxide (VP / VA / GMA) and the diamine (Jeffamine ED-2003) starts immediately after the outlet of the spinneret.
[0096] All membranes obtained had a wall thickness of approximately 49 μm and a lumen between 300 μm and 370 μm.
[0097] Amount in % NMP 62.96 PES E6020 19.00 PVP K30 10.03 PVP K90 1.27 water 4.74 VP / VA / GMA 2.00
[0098] Table 1: Composition of the spinning solution.
[0099] Comparative Example 1
[0100] As a comparative example, Example 1 was repeated with a composition that contained no VP / VA / GMA in the dope solution and no diamine in the voiding solution.
[0101] The nitrogen content of the membranes according to Example 1 and Comparative Example 1 was then determined. In addition, the membranes of Example 1 and Comparative Example 1 were subsequently treated in a Soxhlet apparatus for 7 days and the nitrogen content was determined after this extraction procedure. The results are summarized in Table 2.
[0102] Example 1 Comparative Example 1 N content of untreated film [g / kg film] 5.54 3.21 N content of membrane after Soxhlet extraction [g / kg membrane] 4.99 2.46
[0103] Table 2 : Nitrogen content of the film.
[0104] It is apparent that the nitrogen content of the film according to Example 1 is much higher than the corresponding value of Comparative Example 1, indicating that nitrogen has been built into the film. This is evidence of crosslinking of the epoxy functional groups in the VP / VA / GMA units with the diamine in the film structure.
[0105] Similarly, the residual extracts of these membranes were determined by UV spectroscopy. The results are summarized in Table 3.
[0106] Example 1 Comparative Example 1 UV value of extractables from untreated membrane 5.54 3.21 UV value of membrane extractables after Soxhlet extraction 4.99 2.46
[0107] Table 3 : UV value of film extractables.
[0108] Table 3 shows that less VP / VA / GMA washed out of the membrane than the commonly used PVP. This is a clear indication of cross-linked VP / VA / GMA and a stable hydrophilic low extractable membrane.
[0109] Finally, the membrane according to Example 1 gave 100% retention of the 15 nm gold particles, compared to 57% retention for the membrane according to Comparative Example 1.
Claims
1. A method for producing a modified microporous membrane, comprising: (i) providing a first solution comprising at least one first polymer and at least one epoxy-functional compound, wherein the at least one first polymer is selected from polyvinylidene fluoride, polyethylene and / or polysulfone, and wherein the at least one epoxy-functional compound is a copolymer comprising building blocks comprising at least one epoxy moiety and at least one aliphatic or aromatic alkoxy functional group; (ii) providing a second solution comprising at least one diamine compound, wherein the at least one diamine compound is selected from the group consisting of polyamines, polyetheramines, polyamidoamines, and any combination and mixture thereof; (iii) contacting the first solution with the second solution to obtain a modified microporous membrane comprising at least one first polymer and a crosslinked reaction product of the at least one epoxy-functional compound and the at least one diamine compound; wherein the modified microporous membrane is a hollow fiber membrane; And wherein the first solution is a spinning solution, the second solution is a pore solution, and the first solution and the second solution are brought into contact in a spinneret.
2. The method according to claim 1, wherein the building blocks comprising at least one epoxy moiety are selected from aliphatic or aromatic glycidyl ethers.
3. The method of claim 1, wherein the copolymer further comprises a building block having a moiety selected from the group consisting of: aliphatic, cyclic or aromatic esters; aliphatic, cyclic or aromatic amides; aliphatic, cyclic or aromatic ethers; aliphatic, cyclic or aromatic sulfones; aliphatic, cyclic or aromatic sulfides; aliphatic, cyclic or aromatic sulfonamides; and / or metal chelators.
4. The method of claim 1, wherein the at least one epoxy functional compound has the formula where x, y and z are uniformly distributed. The method according to claim 4 , wherein x+y+z=100. The method of claim 1 , wherein the at least one first polymer is selected from polysulfones.
7. The method of claim 1, wherein the at least one first polymer is selected from polyethersulfone, polyphenylsulfone, or polyarylethersulfone.
8. The method of claim 1, wherein the first solution comprises at least one second polymer.
9. The method of claim 8, wherein the at least one second polymer is a hydrophilic polymer or copolymer.
10. The method according to claim 8, wherein the at least one first polymer is selected from polysulfones and the at least one second polymer is selected from polyvinylpyrrolidone.
11. The method of claim 1, wherein the first solution comprises at least one solvent selected from the group consisting of dimethylformamide, dimethylacetamide, dimethyl sulfoxide, and N-methylpyrrolidone, and any combination or mixture thereof.
12. A modified membrane obtained by the method according to claim 1.
13. Use of the membrane according to claim 12 for microfiltration, nanofiltration or ultrafiltration.
14. Use according to claim 13, wherein the membrane is used for microfiltration, nanofiltration or ultrafiltration of water or an aqueous medium.
15. The use according to claim 13, wherein the use comprises virus filtration.
